ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,202, issued on May 13, was assigned to Rigel Pharmaceuticals Inc. (South San Francisco, Calif.).
"RIP1K inhibitors" was invented by Somasekhar Bhamidipati (Foster City, Calif.), Simon Shaw (Oakland, Calif.), Ihab Darwish (San Carlos, Calif.), Jiaxin Yu (San Carlos, Calif.), Rao Kolluri (Foster City, Calif.), Vanessa Taylor (San Francisco), Esteban Masuda (Menlo Park, Calif.) and Mark Irving (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inh...